Investor Presentaiton

Top-tier talent Differentiated process Fundamental drivers of our investment process • Approach Select best project team based on therapeutic area expertise Flat structure with no organizational silos ROYALTY PHARMA . Scalable platform 良 Diligence Exhaustive research led by decision makers Leverage industry experts for best possible advice Accountability One Royalty Pharma team owns entire deal process Executive leadership involved in every step of a transaction Owner-operator mindset 53

View entire presentation